Get the Stockscreener App
11.14
3.15%
0.34
Cellebrite Di Ltd stock is traded at $11.14, with a volume of 7.84M.
It is up +3.15% in the last 24 hours and down -31.15% over the past month.
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
See More
Previous Close:
$10.80
Open:
$10.83
24h Volume:
7.84M
Relative Volume:
3.08
Market Cap:
$2.78B
Revenue:
$496.43M
Net Income/Loss:
$71.35M
P/E Ratio:
39.10
EPS:
0.2849
Net Cash Flow:
$151.57M
1W Performance:
-30.42%
1M Performance:
-31.15%
6M Performance:
-23.91%
1Y Performance:
-27.14%
1-Day Range:
$10.78
$11.20
1-Week Range:
$9.58
$16.43
52-Week Range:
$9.58
$19.98
Cellebrite Di Ltd Stock (CLBT) Company Profile
Name
Cellebrite Di Ltd
Sector
Industry
Phone
-
Address
-
Compare CLBT vs MSFT, ORCL, PLTR, CRWD, FTNT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CLBT
Cellebrite Di Ltd
|
11.14 | 3.80B | 496.43M | 71.35M | 151.57M | 0.2849 |
MSFT
Microsoft Corp
|
495.40 | 3.66T | 318.27B | 125.22B | 72.92B | 16.79 |
ORCL
Oracle Corp
|
150.52 | 441.52B | 67.36B | 17.31B | -23.69B | 5.8248 |
PLTR
Palantir Technologies Inc
|
174.04 | 411.02B | 5.22B | 2.29B | 2.69B | 0.8876 |
CRWD
Crowdstrike Holdings Inc
|
216.95 | 225.83B | 5.09B | -24.89M | 1.43B | -0.0471 |
FTNT
Fortinet Inc
|
160.01 | 118.01B | 7.11B | 1.95B | 2.44B | 2.5883 |
Cellebrite Di Ltd Stock (CLBT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-28-24 | Reiterated | Needham | Buy |
| Mar-13-24 | Upgrade | William Blair | Mkt Perform → Outperform |
| Feb-16-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-19-23 | Initiated | Craig Hallum | Buy |
| Aug-12-22 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-22 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-24-22 | Initiated | JP Morgan | Overweight |
| Feb-11-22 | Initiated | Deutsche Bank | Buy |
| Dec-02-21 | Initiated | BofA Securities | Buy |
| Oct-21-21 | Initiated | Citigroup | Buy |
View All
Cellebrite Di Ltd Stock (CLBT) Latest News
Cellebrite DI Ltd (CLBT) Stock Up 3.1% and Still Undervalued -- GF Score: 84/100 - GuruFocus
Can Cellebrite DI (NASDAQ:CLBT) Regain Market Confidence? - Kalkine Media
Cellebrite (CLBT) Stock Rebounds As ARR Grows But Outlook Cools - simplywall.st
Cellebrite DI (NASDAQ:CLBT) Posts Earnings Results, Beats Expectations By $0.06 EPS - MarketBeat
Cellebrite DI (NASDAQ:CLBT) Given New $15.00 Price Target at Lake Street Capital - MarketBeat
CLBT|Cellebrite DI Ltd|Price:11.110|Chg%:+0.310 - tradingkey.com
Cellebrite Plunges 29% as New CEO Ramji Slashes 2026 Revenue Outlook - finance.biggo.com
Kaplan Fox is Investigating Cellebrite DI Ltd. (NASDAQ: CLBT) for Potential Securities Law Violations - The Globe and Mail
Cellebrite DI (NASDAQ:CLBT) Given New $16.00 Price Target at JPMorgan Chase & Co. - MarketBeat
Legal Tech Roundup: Cellebrite, LexisNexis - Law360
Cellebrite DI (NASDAQ:CLBT) Sees Unusually-High Trading Volume After Strong Earnings - MarketBeat
DA Davidson Has Lowered Expectations for Cellebrite DI (NASDAQ:CLBT) Stock Price - MarketBeat
Cellebrite DI (CLBT) Cuts Guidance And Changes CEO, Is The Stock Now Cheap? - Yahoo Finance
CLBT SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Cellebrite DI Ltd. - PR Newswire
Cellebrite DI (NASDAQ:CLBT) Given New $12.50 Price Target at Needham & Company LLC - MarketBeat
Needham cuts Cellebrite stock price target on guidance reduction - Investing.com
Deutsche Bank Adjusts Cellebrite DI Price Target to $14 From $20, Maintains Buy Rating - marketscreener.com
Does Cellebrite DI’s Lowered 2026 Outlook and New CEO Reset Its AI Narrative (CLBT)? - Yahoo Finance
Cellebrite DI Insider Sold Shares Worth $2,149,638, According to a Recent SEC Filing - marketscreener.com
ETFs Investing in Cellebrite DI Ltd. Stocks - TradingView
Cellebrite DI (CLBT) Names Shiven Ramji As Next CEO - Yahoo Finance
Cellebrite DI Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Cellebrite DI (CLBT) - Morningstar
Cellebrite shares plunge 30% after Q2 revenue m... - Pluang
Kaplan Fox Launches Securities Probe Into Cellebrite DI Ltd. (CLBT) After 29% Stock Plunge, ARR Shortfall, and Sudden CEO Replacement - Kalkine Media
Cellebrite DI Ltd. Q2 2026 Earnings Call Summary - Yahoo Finance
Cellebrite DI (NASDAQ:CLBT) CEO Thomas Hogan Sells 139,713 Shares of Stock - MarketBeat
Cellebrite (CLBT) CEO gets 339,484-share award and withholds 139,713 shares for taxes - Stock Titan
Cellebrite Announces CEO Transition to Shiven Ramji in Planned Succession - TipRanks
Stocks fall sharply amid fraud probe and mixed earnings, with Cellebrite down 29%. - Pluang
Stock Market Today, Aug. 13: Cellebrite Shares Plummet 29% After Missing Earnings, Cutting 2026 Revenue Guidance - The Globe and Mail
Cellebrite (CLBT) names Shiven Ramji CEO as Thomas Hogan exits leadership - Stock Titan
Cellebrite (CLBT) boosts H1 2026 revenue 17% while net income falls sharply - Stock Titan
Cellebrite DI Earnings and Outlook Raise Doubts. We’re Pulling Our Stock Recommendation. - barrons.com
Cellebrite Q2: This 33% Selloff Looks Like An Overreaction (NASDAQ:CLBT) - Seeking Alpha
Cellebrite DI Releases Q2 2026 Financial Results - AlphaStreet
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against Cellebrite DI Ltd. - PR Newswire
Cellebrite shares drop 31% after ARR shortfall and leadership shakeup call company credibility into question - TechStock²
Cellebrite Shares Plunge Thursday: What's Driving the Move? - TradingView
Cellebrite DI stock hits 52-week low at 10.51 USD By Investing.com - Investing.com Nigeria
Cellebrite DI beats EPS but misses revenue, low... - Pluang
Cellebrite DI Ltd. Stock Analysis: 5-Day Bearish Momentum Insights - The Cryptonomist
Cellebrite DI Sees Unusually High Options Volume (NASDAQ:CLBT) - MarketBeat
Cellebrite Slides as Guidance Cut and ARR Miss Overshadow Q2 Growth - quiverquant.com
Cellebrite Q2 2026 slides: AI ambitions meet execution hurdles - Investing.com
Cellebrite names Shiven Ramji CEO, cuts 2026 revenue outlook By Investing.com - Investing.com South Africa
CENTRAL SECURITIES CORP's Cellebrite DI Ltd(CLBT) Holding History - GuruFocus
Earnings call transcript: Cellebrite cuts outlook in Q2 2026 despite EPS beat - Investing.com
Cellebrite DI Q2 Earnings Call Highlights - MarketBeat
Cellebrite DI Global CRO Marcus Jewell Sells 411 Shares to Cover RSU Tax Obligations - Kalkine Media
Cellebrite DI (NASDAQ:CLBT) Sets New 52-Week LowTime to Sell? - MarketBeat
Full Transcript: Cellebrite DI Q2 2026 Earnings Call - benzinga.com
Cellebrite Di Ltd Stock (CLBT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
8.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):